Ketamine Therapy Clinics in Raleigh, North Carolina

Ketamine Therapy in Raleigh, NC — Local Guide

Ketamine Access in the Research Triangle

Raleigh sits at the apex of North Carolina's Research Triangle, a corridor that also encompasses Durham, Chapel Hill, and Cary — giving residents arguably the densest concentration of academic medical infrastructure in the Southeast. Duke University Health System, UNC Health, and WakeMed all operate within easy driving distance, and this proximity to major research institutions has shaped Raleigh's ketamine therapy landscape into one of the more clinically mature markets on the East Coast. The Ketamine Atlas directory lists 13 providers in the Raleigh metro offering a mix of supervised in-clinic IV infusion programs, Spravato (esketamine) administration sites, and ketamine-assisted psychotherapy (KAP) practices. Telehealth programs that ship compounded ketamine lozenges for at-home use also serve the greater Triangle area, making access meaningfully broader than the clinic count alone suggests.

The Research Triangle's tech-and-biotech workforce skews younger and often carries high levels of work-related stress and treatment-resistant anxiety — a demographic that has driven notable organic search interest in ketamine therapy relative to the metro's population size. UNC's Department of Psychiatry and Duke's Brain Stimulation Program have both published peer-reviewed research on ketamine's antidepressant mechanisms, lending local credibility to the treatment modality.

North Carolina Regulatory Context

Ketamine is a Schedule III controlled substance under federal law and is FDA-approved as an anesthetic; its use for off-label psychiatric and pain conditions is legal nationwide under established clinical prescribing norms. North Carolina does not have any state-specific psychedelic reform legislation — the state operates entirely within the federal framework. Prescribers must hold a valid DEA registration and comply with North Carolina Medical Board standards for off-label prescribing. Spravato (esketamine nasal spray, FDA-approved for treatment-resistant depression in 2019 and for major depressive disorder with acute suicidal ideation in 2020) must be administered in a certified healthcare setting under the FDA's REMS program regardless of state.

What Ketamine Therapy Typically Costs

Nationally, a single IV ketamine infusion session typically runs $400–$800, with a standard induction series of six sessions commonly priced as a package in the $2,400–$4,800 range. These costs are usually paid out-of-pocket because most commercial insurers do not yet cover off-label ketamine infusions. Spravato is the notable exception: because it carries formal FDA approval for TRD, it is covered by many commercial health plans and Medicare/Medicaid with prior authorization, making it the most accessible option for patients with qualifying diagnoses who have insurance. At-home telehealth ketamine programs (such as Mindbloom, Joyous, and similar services) typically charge $200–$500 per month for ongoing programs that include remote medical oversight and compounded oral/sublingual ketamine. No Raleigh-specific price benchmarks have been independently published; the ranges above reflect national norms.

Conditions Treated

Clinicians in Raleigh and the broader Triangle area offer ketamine for:

• Treatment-resistant depression (TRD) — patients who have not responded to two or more adequate antidepressant trials
• Major depressive disorder with suicidal ideation (Spravato-eligible pathway)
• PTSD — including treatment of veterans and first responders, a meaningful population given the proximity of Fort Bragg (now Fort Liberty) roughly 70 miles southwest
• Anxiety disorders — generalized anxiety and social anxiety, often co-occurring with depression
• Chronic pain conditions — complex regional pain syndrome (CRPS), fibromyalgia, and neuropathic pain

Frequently Asked Questions

Is ketamine therapy legal in Raleigh? Yes. Ketamine is a Schedule III prescription drug federally legal for clinical use. North Carolina has no additional state restrictions. A licensed physician, psychiatrist, or CRNA must supervise administration.

What is the difference between IV ketamine and Spravato? IV ketamine delivers the racemic mixture directly into the bloodstream for rapid, controllable dosing; it is off-label and almost never covered by insurance. Spravato (esketamine) is a nasal spray using the S-enantiomer; it is FDA-approved for TRD and MDD with suicidal ideation, must be administered in a clinical setting, and is frequently reimbursable by insurance.

How long does a ketamine infusion session take? A standard psychiatric IV infusion session typically lasts 40–60 minutes for the infusion itself plus pre- and post-monitoring time, making a full appointment roughly 90 minutes.

Can I combine ketamine with my current antidepressants? This is a clinical decision specific to your medication history. Most ketamine programs conduct a full medication review during intake screening. Some medications (particularly MAOIs and benzodiazepines at high doses) may require dose adjustment or washout; your prescribing clinician will advise.

Is there a Research Triangle telehealth option if I can't travel to a clinic? Several national at-home ketamine programs (including Mindbloom and My Ketamine Home) accept North Carolina patients and mail compounded ketamine to your address after a remote intake evaluation. For an overview of at-home ketamine approaches, see the Ketamine Atlas guide to microdosing and at-home ketamine programs at /guides/microdosing-ketamine/.

Nearby Access

If Raleigh clinic availability doesn't match your schedule or needs, Durham (~25 min) and Chapel Hill (~35 min) both host additional providers, and the broader Triangle region collectively offers more options. Greensboro (~90 min west) and the Charlotte metro (~2.5 hrs southwest, with 16 listed providers) provide fallback options for NC patients.

Sources

• FDA: Spravato (esketamine) prescribing information and REMS program — https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211243s003lbl.pdf
• FDA: Ketamine Hydrochloride Injection (Schedule III) — https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016812s046lbl.pdf
• North Carolina Medical Board, Off-Label Prescribing Policy — https://www.ncmedboard.org/
• American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3) — https://www.askp3.org/
• Murrough JW et al., "Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression," Arch Gen Psychiatry, 2013 — https://doi.org/10.1001/archgenpsychiatry.2012.1687